Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATIC | P31939 | 2/20 | 0.64 |
| ▸ | FBP1 | P09467 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | AHCY | P23526 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29152304 | 0.86 | ATIC (0.47) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL938225 | 0.83 | ATIC (0.60) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL28773388 | 0.83 | ATIC (0.47) | ATICFBP1KDM4ETSHRTDP1 | |
| Faicar SCHEMBL851406 | 0.78 | ATIC (1.00) | ATICFBP1KDM4ETSHRTDP1 | |
| Faicar SCHEMBL4360247 | 0.78 | ATIC (1.00) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL7139991 | 0.78 | ATIC (0.73) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL7139997 | 0.78 | ATIC (0.73) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL20298607 | 0.77 | ATIC (0.40) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL940609 | 0.77 | ATIC (0.40) | ATICFBP1KDM4ETSHRTDP1 | |
| SCHEMBL850150 | 0.76 | FBP1 (0.49) | ATICFBP1KDM4ETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8494779-B2 | Method for screening essential metabolites in growth of microorganisms | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| US-20240018559-A1 | GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS | ACIES BIO D.O.O. (SI) | 2024-01-18 | — | — | US | disclosed |
| EP-3532626-B1 | METHOD FOR PRODUCING OBJECTIVE SUBSTANCE | AJINOMOTO KK (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-11680279-B2 | Method for producing objective substance | AJINOMOTO CO., INC. (JP) | 2023-06-20 | — | — | US | disclosed |
| WO-2022231037-A1 | NOVEL VARIANT, AND METHOD FOR PRODUCING IMP USING SAME | 씨제이제일제당 (주) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022231370-A1 | NOVEL BIFUNCTIONAL PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE VARIANT AND METHOD FOR PRODUCING IMP USING SAME | 씨제이제일제당 (주) | 2022-11-03 | — | — | WO | disclosed |
| EP-4006139-A1 | GENETICALLY ENGINEERED BACTERIUM CAPABLE OF PRODUCING CYTOKININS WITH ISOPRENOID SIDE CHAINS | Acies Bio d.o.o. (SI) | 2022-06-01 | — | — | EP | disclosed |
| EP-3406727-B1 | METHOD FOR PRODUCING OBJECTIVE SUBSTANCE | AJINOMOTO KK (JP) | 2021-08-04 | — | — | EP | disclosed |
| EP-3502263-B1 | METHOD FOR PRODUCING VANILLIC ACID | AJINOMOTO KK (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-10883124-B2 | Method for producing objective substance | AJINOMOTO CO., INC. (JP) | 2021-01-05 | — | — | US | disclosed |
| WO-2018079683-A1 | METHOD FOR PRODUCING OBJECTIVE SUBSTANCE | AJINOMOTO CO., INC. (JP) | 2018-05-03 | — | — | WO | disclosed |
| EP-2401696-B1 | MAMMALIAN CELL LINE MODELS AND RELATED METHODS | INTREXON CEU INC (US) | 2017-06-21 | — | — | EP | disclosed |
| US-20140309186-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION | 2014-10-16 | — | — | US | disclosed |
| US-8494779-B2 | Method for screening essential metabolites in growth of microorganisms | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | disclosed |
| US-20120191434-A1 | ARTICLES OF MANUFACTURE AND METHODS FOR MODELING CHINESE HAMSTER OVARY (CHO) CELL METABOLISM | GT LIFE SCIENCES, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| US-20110246081-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-06 | — | — | US | disclosed |
| US-7869957-B2 | Methods and systems to identify operational reaction pathways | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-11 | — | — | US | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | disclosed |